{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Gossamer Bio, Inc."},"Symbol":{"label":"Symbol","value":"GOSS"},"Address":{"label":"Address","value":"3013 SCIENCE PARK ROAD,SUITE 200, SAN DIEGO, California, 92121, United States"},"Phone":{"label":"Phone","value":"+1 858 684-1300"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma."},"CompanyUrl":{"label":"Company Url","value":"https://www.gossamerbio.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Bryan Giraudo","title":"Chief Operating & Financial Officer"},{"name":"Christian Waage","title":"EVP-Technical Operations & Administration"},{"name":"Faheem Hasnain","title":"Chairman, President & Chief Executive Officer"},{"name":"Rainer Zimmermann","title":"Vice President-Medical Affairs"},{"name":"Richard Aranda","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}